Chang‐Yong Tsao

1.3k total citations
45 papers, 874 citations indexed

About

Chang‐Yong Tsao is a scholar working on Molecular Biology, Genetics and Clinical Biochemistry. According to data from OpenAlex, Chang‐Yong Tsao has authored 45 papers receiving a total of 874 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 11 papers in Genetics and 8 papers in Clinical Biochemistry. Recurrent topics in Chang‐Yong Tsao's work include Muscle Physiology and Disorders (15 papers), Neurogenetic and Muscular Disorders Research (11 papers) and Mitochondrial Function and Pathology (10 papers). Chang‐Yong Tsao is often cited by papers focused on Muscle Physiology and Disorders (15 papers), Neurogenetic and Muscular Disorders Research (11 papers) and Mitochondrial Function and Pathology (10 papers). Chang‐Yong Tsao collaborates with scholars based in United States, France and Germany. Chang‐Yong Tsao's co-authors include Jerry R. Mendell, Kimberly Tallian, Warren Lo, Sara Shanske, Darryl C. De Vivo, Milap C. Nahata, Mark Luquette, Michio Hirano, Ali Naini and Olimpia Musumeci and has published in prestigious journals such as Neurology, PEDIATRICS and The Journal of Pediatrics.

In The Last Decade

Chang‐Yong Tsao

41 papers receiving 847 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chang‐Yong Tsao United States 17 548 163 158 141 137 45 874
Yehuda Shapira Israel 17 459 0.8× 221 1.4× 98 0.6× 80 0.6× 139 1.0× 52 928
Ryoji Minami Japan 14 619 1.1× 49 0.3× 129 0.8× 37 0.3× 94 0.7× 55 973
Maria Margherita Mancardi Italy 15 178 0.3× 47 0.3× 44 0.3× 149 1.1× 112 0.8× 86 696
Maria Kinali United Kingdom 14 280 0.5× 19 0.1× 244 1.5× 46 0.3× 47 0.3× 20 584
Lubov Blumkin Israel 14 214 0.4× 22 0.1× 27 0.2× 101 0.7× 161 1.2× 31 502
S. Binelli Italy 20 209 0.4× 52 0.3× 90 0.6× 387 2.7× 185 1.4× 43 926
J. Mayhew United States 9 229 0.4× 64 0.4× 89 0.6× 126 0.9× 62 0.5× 25 563
Jessika Johannsen Germany 13 252 0.5× 20 0.1× 200 1.3× 23 0.2× 62 0.5× 45 579
Cláudia Ferreira da Rosa Sobreira Brazil 11 275 0.5× 46 0.3× 27 0.2× 72 0.5× 42 0.3× 35 445
Véronique Humbertclaude France 14 319 0.6× 32 0.2× 54 0.3× 225 1.6× 137 1.0× 29 631

Countries citing papers authored by Chang‐Yong Tsao

Since Specialization
Citations

This map shows the geographic impact of Chang‐Yong Tsao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chang‐Yong Tsao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chang‐Yong Tsao more than expected).

Fields of papers citing papers by Chang‐Yong Tsao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chang‐Yong Tsao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chang‐Yong Tsao. The network helps show where Chang‐Yong Tsao may publish in the future.

Co-authorship network of co-authors of Chang‐Yong Tsao

This figure shows the co-authorship network connecting the top 25 collaborators of Chang‐Yong Tsao. A scholar is included among the top collaborators of Chang‐Yong Tsao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chang‐Yong Tsao. Chang‐Yong Tsao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bekircan‐Kurt, Can Ebru, Shoba Subramanian, M. Iammarino, et al.. (2025). Transitioning From Nusinersen to Risdiplam for Spinal Muscular Atrophy in Clinical Practice: A Single‐Center Experience. Muscle & Nerve. 71(3). 414–421. 3 indexed citations
2.
Miller, N., Lindsay N. Alfano, M. Iammarino, et al.. (2020). Natural History of Steroid-Treated Young Boys With Duchenne Muscular Dystrophy Using the NSAA, 100m, and Timed Functional Tests. Pediatric Neurology. 113. 15–20. 18 indexed citations
3.
Alfano, Lindsay N., N. Miller, M. Iammarino, et al.. (2019). ACTIVE (Ability Captured Through Interactive Video Evaluation) workspace volume video game to quantify meaningful change in spinal muscular atrophy. Developmental Medicine & Child Neurology. 62(3). 303–309. 9 indexed citations
4.
Tsao, Chang‐Yong. (2015). Effective Treatment With Albuterol in DOK7 Congenital Myasthenic Syndrome in Children. Pediatric Neurology. 54. 85–87. 13 indexed citations
5.
Tsao, Chang‐Yong. (2014). Cerebellar Ataxia, Vertical Supranuclear Gaze Palsy, Sensorineural Deafness, Epilepsy, Dementia, and Hallucinations in an Adolescent Male. Seminars in Pediatric Neurology. 21(2). 106–108. 4 indexed citations
6.
Rosales, Xiomara Q. & Chang‐Yong Tsao. (2011). Childhood Onset of Limb-Girdle Muscular Dystrophy. Pediatric Neurology. 46(1). 13–23. 17 indexed citations
7.
Tsao, Chang‐Yong & Jerry R. Mendell. (2009). Partial Epilepsy in an Adolescent Male With Limb-Girdle Muscular Dystrophy 1B. Journal of Child Neurology. 24(3). 346–348. 5 indexed citations
8.
Tsao, Chang‐Yong, et al.. (2007). Isolated neurosarcoidosis presenting as headache and multiple brain and spinal cord lesions mimicking central nervous system metastases. Brain and Development. 29(8). 514–518. 20 indexed citations
9.
Tsao, Chang‐Yong, et al.. (2006). Coexisting Muscular Dystrophies and Epilepsy in Children. Journal of Child Neurology. 21(2). 148–150. 19 indexed citations
10.
Tallian, Kimberly, Milap C. Nahata, Warren Lo, & Chang‐Yong Tsao. (2004). Pharmacokinetics of gabapentin in paediatric patients with uncontrolled seizures. Journal of Clinical Pharmacy and Therapeutics. 29(6). 511–515. 17 indexed citations
11.
Tsao, Chang‐Yong. (2004). Effective Treatment With Oxcarbazepine in Paroxysmal Kinesigenic Choreoathetosis. Journal of Child Neurology. 19(4). 300–301. 13 indexed citations
12.
Tsao, Chang‐Yong, Gail E. Herman, Daniel R. Boué, et al.. (2003). Leigh Disease With Mitochondrial DNA A8344G Mutation: Case Report and Brief Review. Journal of Child Neurology. 18(1). 62–64. 18 indexed citations
13.
Tsao, Chang‐Yong, et al.. (2002). Guillain-Barré syndrome.. PubMed. 13(3). 487–94. 8 indexed citations
14.
Tsao, Chang‐Yong, Jerry R. Mendell, & Dennis Bartholomew. (2001). High Mitochondrial DNA T8993G Mutation (>90%) Without Typical Features of Leigh's and NARP Syndromes. Journal of Child Neurology. 16(7). 533–535. 25 indexed citations
15.
Sue, Carolyn M., Claudio Bruno, Antoni L. Andreu, et al.. (1999). Infantile encephalopathy associated with the MELAS A3243G mutation. The Journal of Pediatrics. 134(6). 696–700. 52 indexed citations
16.
Tsao, Chang‐Yong & Jerry R. Mendell. (1999). The Childhood Muscular Dystrophies: Making Order Out of Chaos. Seminars in Neurology. 19(1). 9–23. 11 indexed citations
17.
Mendell, Joshua T., Shirly G. Panicker, Chang‐Yong Tsao, et al.. (1998). Novel compound heterozygous laminina2-chain gene (LAMA2) mutations in congenital muscular dystrophy. Human Mutation. 12(2). 135–135. 5 indexed citations
18.
Prior, Thomas W., A C Papp, Pamela J. Snyder, et al.. (1997). Dystrophin expression in a Duchenne muscular dystrophy Patient with a frame shift deletion. Neurology. 48(2). 486–488. 28 indexed citations
19.
Tsao, Chang‐Yong, et al.. (1997). Leigh Syndrome, Cytochrome C Oxidase Deficiency and Hypsarrhythmia with Infantile Spasms. Clinical Electroencephalography. 28(4). 214–217. 9 indexed citations
20.
Tallian, Kimberly, et al.. (1996). Gabapentin Associated with Aggressive Behavior in Pediatric Patients with Seizures. Epilepsia. 37(5). 501–502. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yehuda Shapira Breakdown of academic impact, for papers by Ryoji Minami Breakdown of academic impact, for papers by Maria Margherita Mancardi Breakdown of academic impact, for papers by Maria Kinali Breakdown of academic impact, for papers by Lubov Blumkin Breakdown of academic impact, for papers by S. Binelli Breakdown of academic impact, for papers by J. Mayhew Breakdown of academic impact, for papers by Jessika Johannsen Breakdown of academic impact, for papers by Cláudia Ferreira da Rosa Sobreira Breakdown of academic impact, for papers by Véronique Humbertclaude
Rankless by CCL
2026